Category - Pharma Industry News
Sanofi to invest €400m annually in mRNA vaccines facility
Anavex’s CNS drug slows progression of motor and non-motor symptoms in Parkinson’s disease
Kite’s CAR-T therapy Yescarta shows positive results in second-line lymphoma study
Study finds mixed vaccine schedules provide strong immune response against COVID-19
Sanofi plans €400m investment in mRNA vaccines ‘centre of excellence’
BioMarin resubmits haemophilia A gene therapy to the EMA
ABPI launches updated Code of Practice
‘Mix and match’ COVID-19 vaccine study yields promising results